Project
A dose blind, multicenter, extension study to determine the safety and efficasy of 2 doses of BG00012 monotherapy with Relapsin Remitting Multiple Sclerosis
Automatically Closed · 2010 until 2020
Müller Stefanie, Vehoff Jochen
No results found.